The increase in allergy and extended challenges

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

The increase in allergy and extended challenges. / Linneberg, A.

I: Allergy, Bind 66 Suppl 95, 07.2011, s. 1-3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Linneberg, A 2011, 'The increase in allergy and extended challenges', Allergy, bind 66 Suppl 95, s. 1-3. https://doi.org/10.1111/j.1398-9995.2011.02619.x

APA

Linneberg, A. (2011). The increase in allergy and extended challenges. Allergy, 66 Suppl 95, 1-3. https://doi.org/10.1111/j.1398-9995.2011.02619.x

Vancouver

Linneberg A. The increase in allergy and extended challenges. Allergy. 2011 jul.;66 Suppl 95:1-3. https://doi.org/10.1111/j.1398-9995.2011.02619.x

Author

Linneberg, A. / The increase in allergy and extended challenges. I: Allergy. 2011 ; Bind 66 Suppl 95. s. 1-3.

Bibtex

@article{5573dfa986e1426aa096f033c57ac86d,
title = "The increase in allergy and extended challenges",
abstract = "The prevalence of allergic diseases shows a well-documented increase in developed countries over several decades. Currently, 20-25% of European adults are affected. Westernisation, urbanisation, and affluence contribute to allergy development, so allergy is expected to increase in developing countries in the future. Identifying primary causes, developing new therapies, and increasing treatment access may interrupt the allergic epidemic.",
keywords = "Adult, Allergens, Developed Countries, Humans, Immunization, Immunoglobulin E, Prevalence, Respiratory Hypersensitivity, Risk Factors, Journal Article",
author = "A Linneberg",
note = "{\textcopyright} 2011 John Wiley & Sons A/S.",
year = "2011",
month = jul,
doi = "10.1111/j.1398-9995.2011.02619.x",
language = "English",
volume = "66 Suppl 95",
pages = "1--3",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley Online",

}

RIS

TY - JOUR

T1 - The increase in allergy and extended challenges

AU - Linneberg, A

N1 - © 2011 John Wiley & Sons A/S.

PY - 2011/7

Y1 - 2011/7

N2 - The prevalence of allergic diseases shows a well-documented increase in developed countries over several decades. Currently, 20-25% of European adults are affected. Westernisation, urbanisation, and affluence contribute to allergy development, so allergy is expected to increase in developing countries in the future. Identifying primary causes, developing new therapies, and increasing treatment access may interrupt the allergic epidemic.

AB - The prevalence of allergic diseases shows a well-documented increase in developed countries over several decades. Currently, 20-25% of European adults are affected. Westernisation, urbanisation, and affluence contribute to allergy development, so allergy is expected to increase in developing countries in the future. Identifying primary causes, developing new therapies, and increasing treatment access may interrupt the allergic epidemic.

KW - Adult

KW - Allergens

KW - Developed Countries

KW - Humans

KW - Immunization

KW - Immunoglobulin E

KW - Prevalence

KW - Respiratory Hypersensitivity

KW - Risk Factors

KW - Journal Article

U2 - 10.1111/j.1398-9995.2011.02619.x

DO - 10.1111/j.1398-9995.2011.02619.x

M3 - Journal article

C2 - 21668839

VL - 66 Suppl 95

SP - 1

EP - 3

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

ER -

ID: 173161805